Claims Study Shows Better Glycemic Control, Less Switching With Canagliflozin Than Dapagliflozin | Latest News RSS feed

Claims Study Shows Better Glycemic Control, Less Switching With Canagliflozin Than Dapagliflozin - Latest News


Lexicon Pharmaceuticals' CEO Hosts 2013 Research and Development Day Conference (Transcript)

Also if you look at the amount of urinary glucose excretion, this is someone less than that’s been higher doses of canagliflozin ... end of the study both the lower and the higher dose of LX4211 are a... read more

Real-World Study of More than 700,000 People with Type 2 Diabete - KLTV.com - Tyler, Longview, Jacksonville |ETX News

First head-to-head real-world study to ... large U.S. medical claims databases, and included 714,582 adults with T2D across multiple categories: those who took INVOKANA ® (142,800), other SGLT2i thera... read more

Zafgen, Inc. (ZFGN)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file repo... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us